TrialCancer chemotherapy and pharmacology2013

Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.

S Fushida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.